Potential molecular targets in chemopreventative action of celecoxib: a proteomics analysis of J774.A1 macrophage-like cell line

Mol Biosyst. 2011 Apr;7(4):1306-11. doi: 10.1039/c0mb00201a. Epub 2011 Jan 24.

Abstract

The overexpression of cyclooxygenase-2 (COX-2) enzyme has been strongly contributed to tumorigenesis. The efficacy of celecoxib as a selective COX-2 inhibitor has been shown in many studies, but the underlying mechanism as a chemopreventative agent has not yet been well known. For better understanding the chemopreventative molecular mechanisms, we used a comparative proteomics analysis of lipopolysaccharide (LPS) treated and untreated J774.A1 macrophage-like cell lines before and after treatment with celecoxib. Our findings define the contribution of several interesting proteins, including ferritin heavy chain, glyoxalase-1, cofilin, vimentin, and galectin-1, which could extend our understanding of the chemopreventative effects of celecoxib and provide new valuable tools for further anticancer research.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Celecoxib
  • Cell Line, Tumor
  • Chemoprevention
  • Cyclooxygenase 2 Inhibitors* / metabolism
  • Cyclooxygenase 2 Inhibitors* / pharmacology
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects*
  • Macrophages / metabolism*
  • Mice
  • Neoplasms / physiopathology
  • Proteomics*
  • Pyrazoles* / metabolism
  • Pyrazoles* / pharmacology
  • Sulfonamides* / metabolism
  • Sulfonamides* / pharmacology

Substances

  • Antineoplastic Agents
  • Cyclooxygenase 2 Inhibitors
  • Lipopolysaccharides
  • Pyrazoles
  • Sulfonamides
  • Celecoxib